» Articles » PMID: 37006536

Pre-emptive Living Donor Kidney Transplantation: A Public Health Justification to Change the Default

Overview
Specialty Public Health
Date 2023 Apr 3
PMID 37006536
Authors
Affiliations
Soon will be listed here.
Citing Articles

Health-related quality of life in living kidney donors participating in kidney exchange programmes.

van de Laar S, Wiltschut B, Oudmaijer C, Muller K, Massey E, Porte R Clin Kidney J. 2025; 18(2):sfae374.

PMID: 39917536 PMC: 11799774. DOI: 10.1093/ckj/sfae374.


Favorable Living Donor Kidney Transplantation Outcomes within a National Kidney Exchange Program: A Propensity Score-Matching Analysis.

van de Laar S, de Weerd A, Bemelman F, Idu M, de Vries A, Alwayn I Clin J Am Soc Nephrol. 2025; 20(3):440-450.

PMID: 39879095 PMC: 11906000. DOI: 10.2215/CJN.0000000611.


Understanding the Role of Trust in Healthcare and Intentions to Pursue Live Donor Kidney Transplant Among African American End Stage Kidney Disease Patients.

Arriola K, Barrett D, Pastan S, Perryman J, DuBay D, Di M J Racial Ethn Health Disparities. 2025; .

PMID: 39786710 DOI: 10.1007/s40615-024-02229-0.


Push toward pre-emptive kidney transplantation - for sure?.

Cseprekal O, Jacquelinet C, Massy Z Clin Kidney J. 2024; 17(12):sfae335.

PMID: 39698373 PMC: 11653007. DOI: 10.1093/ckj/sfae335.


Engagement With Sports After Solid Organ Transplant.

Saji N, Kumar A, Joseph J, Kumar P, Kartha A, Bijlani K Cureus. 2024; 16(9):e68622.

PMID: 39371776 PMC: 11452357. DOI: 10.7759/cureus.68622.


References
1.
Meier-Kriesche H, Kaplan B . Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation. 2002; 74(10):1377-81. DOI: 10.1097/00007890-200211270-00005. View

2.
Mjoen G, Hallan S, Hartmann A, Foss A, Midtvedt K, Oyen O . Long-term risks for kidney donors. Kidney Int. 2013; 86(1):162-7. DOI: 10.1038/ki.2013.460. View

3.
Amaral S, Sayed B, Kutner N, Patzer R . Preemptive kidney transplantation is associated with survival benefits among pediatric patients with end-stage renal disease. Kidney Int. 2016; 90(5):1100-1108. PMC: 5072842. DOI: 10.1016/j.kint.2016.07.028. View

4.
Matas A, Schnitzler M . Payment for living donor (vendor) kidneys: a cost-effectiveness analysis. Am J Transplant. 2004; 4(2):216-21. DOI: 10.1046/j.1600-6143.2003.00290.x. View

5.
Marlais M, Martin K, Marks S . Improved renal allograft survival for pre-emptive paediatric renal transplant recipients in the UK. Arch Dis Child. 2021; 106(12):1191-1194. PMC: 8666698. DOI: 10.1136/archdischild-2020-321277. View